OPTIMA creates a virtual model of a patient's heart so doctors only need to operate once.

 

cff5.jpg

 

 

Starting this fall, the FDA plans to trial an innovative new computational medicine approach to heart surgery with 160 patients in the US. The procedure, called Optimal Target Identification via Modelling of Arrhythmogenesis (OPTIMA, for short), involves creating a virtual model of a patient's heart before doctors ever operate. The procedure promises to significantly reduce the number of surgeries doctors will need to perform to treat individuals with irregular heartbeats.